Dan Liljenquist is Senior Vice President and Chief Strategy Officer (CSO) of Intermountain Healthcare, responsible for the organization’s strategic priorities as well as overseeing its Corporate Development, Government Relations, and Care Transformation teams. Prior to joining Intermountain in 2012, Liljenquist served in the Utah State Senate and was nationally recognized for his work on Medicaid and public-sector pension reforms.
Liljenquist is the architect and current Board Chair of Civica Rx, a new and nationally acclaimed nonprofit generic drug company established to reduce chronic generic drug shortages and price gouging, which have negatively impacted patient care for over a decade. In 2021, he was recognized by Modern Healthcare as one of the “100 Most Influential People in Healthcare” and as one of the “Top 25 Innovators in Healthcare.”
Liljenquist also worked as Bain & Company. He received his Juris Doctorate from The University of Chicago Law School.